Improved rheumatoid digital vasculitis in a patient treated with TNFα agent blocking (infliximab)

Rheumatology International

Volumn 28, Issue 12, 2008, Pages 1253-1255

  Benucci, Maurizio ^a   Li Gobbi, Francesca ^a   Saviola, Gianantonio ^b   Manfredi, Mariangela ^a  

^a SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^b IRCCS   (Italy)

Author keywords

Rheumatoid vasculitis; TNF blocking agents

Indexed keywords

CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

AGED; AMPUTATION; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE INCREASE; FEMALE; HUMAN; LABORATORY TEST; PRIORITY JOURNAL; RHEUMATIC VASCULITIS; RHEUMATOID ARTHRITIS;

AGED; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; FEMALE; FINGERS; HUMANS; NECROSIS; TUMOR NECROSIS FACTOR-ALPHA; VASCULITIS;

EID: 51649091368     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-008-0592-x     Document Type: Article

References (15)

1. MS Genta RM Genta C Gabay 2006 Systemic rheumatoid vasculitis: a review Semin Arthritis Rheum 36 2 88 98 Review
2. F Atzeni A Doria M Carrabba M Turiel P Sarzi-Puttini 2007 Potential target of infliximab in autoimmune and inflammatory diseases Autoimmun Rev 6 8 529 536
3. C Salvarani P Macchioni W Mantovani F Rossi M Veneziani L Boiardi L Lodi I Portioli 1992 Extraarticular manifestations of rheumatoid arthritis and HLA antigens in northern Italy J Rheumatol 19 2 242 246
4. ML Westedt P Herbrink JL Molenaar E de Vries P Verlaan T Stijnen A Cats J Lindeman 1985 Rheumatoid factors in rheumatoid arthritis and vasculitis Rheumatol Int 5 5 209 214
5. S Pai L Pai R Birkenfeldt 1998 Correlation of serum IgA rheumatoid factor levels with disease severity in rheumatoid arthritis Scand J Rheumatol 27 4 252 256
6. CJ Elson DG Scott DR Blake PA Bacon PD Holt 1983 Complement activating rheumatoid factor containing complexes in patients with rheumatoid vasculitis Ann Rheum Dis 42 147 150
7. RP Kimberly J Wu AW Gibson K Su H Qin X Li JC Edberg 2002 Diversity and duplicity: human FCgamma receptors in host defense and autoimmunity Immunol Res 26 1-3 177 189 Review
8. RM Flipo A Janin E Hachulla E Houvenagel A Foulet T Cardon 1994 Labial salivary gland biopsy assessment in rheumatoid vasculitis Ann Rheum Dis 53 648 652
9. CM Magro AN Crowson 2003 The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients J Cutan Pethol 30 1 10
10. T Simonart P Durez J Margaux J Van Geertruyden D Goldschmidt D Parent 1997 Cutaneous necrotizing vasculitis after low dose methotrexate therapy for rheumatoid arthritis: a possible manifestation of methotrexate hypersensitivity Clin Rheumatol 16 6 623 625
11. O Kaye CC Beckers P Paquet JE Arrese GE Pierard MG Malaise 1996 The frequency of cutaneous vasculitis is not increased in patients with rheumatoid arthritis treated with methotrexate J Rheumatol 23 2 253 257
12. DG Scott PA Bacon 1984 Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis Am J Med 76 3 377 384
13. C Garcia Porrua MA Gonzalez-Gay 2002 Successful treatment of refractory mononeuritis multiplex secondary to rheumatoid arthritis with the anti-tumour necrosis factor alpha monoclonal antibody infliximab Rheumatology 41 2 234 235
14. L Unger M Kayser HG Nusslein 2003 Successful treatment of severe rheumatoid vasculitis by infliximab Ann Rheum Dis 62 587 588
15. Ashok D, Dubey S, Tomlinson I (2007) C-ANCA positive systemic vasculitis in a patient with rheumatoid arthritis treated with infliximab. Clin Rheumatol. Aug 22; [Epub ahead of print]